Article: Neonatal mitochondrial hepatoencephalopathy caused by novel GFM1 mutations

Disorders caused by defects in the mitochondrial translation system are clinically and genetically heterogeneous. The elongation phase of mitochondrial protein synthesis requires, among many other components, three nuclear-encoded elongation factors: EFTu (TUFM; 602389), EFTs (TSFM; 604723), and EFG1 (GFM1; 606639). Mutations have been identified in the genes encoding all three elongation factors, and they result in combined respiratory chain deficiencies and severe phenotypes with an early fatal outcome. So far, only eleven patients have been reported with mutations in GFM1. Here we describe an additional three patients with novel GFM1 mutations. Our results confirm the tissue-specific effect of GFM1 mutations, since we found only slightly decreased respiratory chain enzyme activities in muscle and fibroblasts, but a severe deficiency in the liver. Hence, a thorough biochemical evaluation is important to guide genetic investigation in patients suspected for a mitochondrial disorder.

Citing Articles

UPR activation improves pathological alterations in cellular models of mitochondrial diseases.

Suarez-Rivero J, Pastor-Maldonado C, Povea-Cabello S, Alvarez-Cordoba M, Villalon-Garcia I, Talaveron-Rey M Orphanet J Rare Dis. 2022; 17(1):204.

PMID: 35581596 PMC: 9115953. DOI: 10.1186/s13023-022-02331-8.

Mitochondrial Protein Translation: Emerging Roles and Clinical Significance in Disease.

Wang F, Zhang D, Zhang D, Li P, Gao Y Front Cell Dev Biol. 2021; 9:675465.

PMID: 34277617 PMC: 8280776. DOI: 10.3389/fcell.2021.675465.

Mitochondrial diseases: expanding the diagnosis in the era of genetic testing.

Saneto R J Transl Genet Genom. 2021; 4:384-428.

PMID: 33426505 PMC: 7791531. DOI: 10.20517/jtgg.2020.40.

[Analysis of gene mutations in a family with combined oxidative phosphorylation deficiency 1].

Shen Y, Yan K, Dong M, Yang R, Huang X Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020; 49(5):574-580.

PMID: 33210482 PMC: 8800753. DOI: 10.3785/j.issn.1008-9292.2020.10.04.

Clinical and molecular findings in a family expressing a novel heterozygous variant of the G elongation factor mitochondrial 1 gene.

Su C, Wang F Exp Ther Med. 2020; 20(6):173.

PMID: 33093908 PMC: 7571333. DOI: 10.3892/etm.2020.9303.

References

1.

Smeitink J, Elpeleg O, Antonicka H, Diepstra H, Saada A, Smits P . Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs. Am J Hum Genet. 2006; 79(5):869-77. PMC: 1698578. DOI: 10.1086/508434. View

2.

Calvo S, Compton A, Hershman S, Lim S, Lieber D, Tucker E . Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci Transl Med. 2012; 4(118):118ra10. PMC: 3523805. DOI: 10.1126/scitranslmed.3003310. View

3.

Smits P, Antonicka H, van Hasselt P, Weraarpachai W, Haller W, Schreurs M . Mutation in subdomain G' of mitochondrial elongation factor G1 is associated with combined OXPHOS deficiency in fibroblasts but not in muscle. Eur J Hum Genet. 2010; 19(3):275-9. PMC: 3062000. DOI: 10.1038/ejhg.2010.208. View

4.

Balasubramaniam S, Choy Y, Talib A, Norsiah M, van den Heuvel L, Rodenburg R . Infantile Progressive Hepatoencephalomyopathy with Combined OXPHOS Deficiency due to Mutations in the Mitochondrial Translation Elongation Factor Gene GFM1. JIMD Rep. 2013; 5:113-22. PMC: 3509912. DOI: 10.1007/8904_2011_107. View

5.

Ostergaard E, Hansen F, Sorensen N, Duno M, Vissing J, Larsen P . Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. Brain. 2007; 130(Pt 3):853-61. DOI: 10.1093/brain/awl383. View

6.

Galmiche L, Serre V, Beinat M, Zossou R, Assouline Z, Lebre A . Toward genotype phenotype correlations in GFM1 mutations. Mitochondrion. 2011; 12(2):242-7. DOI: 10.1016/j.mito.2011.09.007. View

7.

Wibrand F, Jeppesen T, Frederiksen A, Olsen D, Duno M, Schwartz M . Limited diagnostic value of enzyme analysis in patients with mitochondrial tRNA mutations. Muscle Nerve. 2009; 41(5):607-13. DOI: 10.1002/mus.21541. View

8.

Valente L, Tiranti V, Marsano R, Malfatti E, Fernandez-Vizarra E, Donnini C . Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. Am J Hum Genet. 2006; 80(1):44-58. PMC: 1785320. DOI: 10.1086/510559. View

9.

Coenen M, Antonicka H, Ugalde C, Sasarman F, Rossi R, Heister J . Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. N Engl J Med. 2004; 351(20):2080-6. DOI: 10.1056/NEJMoa041878. View

10.

Antonicka H, Sasarman F, Kennaway N, Shoubridge E . The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1. Hum Mol Genet. 2006; 15(11):1835-46. DOI: 10.1093/hmg/ddl106. View

11.

Smits P, Smeitink J, van den Heuvel L . Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies. J Biomed Biotechnol. 2010; 2010:737385. PMC: 2854570. DOI: 10.1155/2010/737385. View

Neonatal Mitochondrial Hepatoencephalopathy Caused by Novel GFM1 Mutations